Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-12
DOI
10.1186/s12967-020-02362-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel mutation in the mouse Pcsk1 gene showing obesity and diabetes
- (2020) Nor I. A. Muhsin et al. MAMMALIAN GENOME
- STAT 3 Signaling Pathway is Implicated in Keloid Pathogenesis by Preliminary Transcriptome and Open Chromatin Analyses
- (2019) Yun‐Shain Lee et al. EXPERIMENTAL DERMATOLOGY
- Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia
- (2019) Mark Trinder et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tea Consumption and Health Outcomes: Umbrella Review of Meta‐Analyses of Observational Studies in Humans
- (2019) Mengshi Yi et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption
- (2019) Dylan O’Neill Rothenberg et al. Nutrients
- Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism
- (2018) Sheng-Hua Yang et al. Cardiovascular Diabetology
- Pinostrobin Inhibits Proprotein Convertase Subtilisin/Kexin-type 9 (PCSK9) Gene Expression through the Modulation of FoxO3a Protein in HepG2 Cells
- (2018) Wan-Yun Gao et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis
- (2018) Luis Masana et al. Journal of Clinical Lipidology
- Association between lipoprotein (a) and proprotein convertase substilisin/kexin type 9 in patients with heterozygous familial hypercholesterolemia: A case‐control study
- (2018) Di Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas
- (2018) Majambu Mbikay et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet
- (2018) Qiming Wang et al. Kardiologia Polska
- PCSK9 inhibitors: clinical evidence and implementation
- (2018) Marc S. Sabatine Nature Reviews Cardiology
- Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells
- (2017) Kohei Kitamura et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Functional foods and dietary supplements for the management of dyslipidaemia
- (2017) Paola M. Hunter et al. Nature Reviews Endocrinology
- Regulation of PCSK9 by nutraceuticals
- (2017) Amir Abbas Momtazi et al. PHARMACOLOGICAL RESEARCH
- Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management
- (2017) T.P. Johnston et al. PHARMACOLOGICAL RESEARCH
- Effects of green tea catechin extract on serum lipids in postmenopausal women: a randomized, placebo-controlled clinical trial
- (2016) Hamed Samavat et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial
- (2016) I-Ju Chen et al. CLINICAL NUTRITION
- Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis
- (2016) Jun Pang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells
- (2016) Chuan-Jue Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Red Raspberry Phenols Inhibit Angiogenesis: A Morphological and Subcellular Analysis Upon Human Endothelial Cells
- (2016) M. Sousa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The Combination of Green Tea Extract and Eriodictyol Inhibited High-Fat/High-Sucrose Diet-Induced Cholesterol Upregulation Is Accompanied by Suppression of Cholesterol Synthesis Enzymes
- (2016) Mai YAMASHITA et al. JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
- Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells
- (2016) Hung-Chen Chen et al. PLoS One
- Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial
- (2015) James I Dower et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
- (2015) Nathalie Bergeron et al. CIRCULATION
- Black tea consumption and serum cholesterol concentration: Systematic review and meta-analysis of randomized controlled trials
- (2015) Yimin Zhao et al. CLINICAL NUTRITION
- PCSK9 inhibition in LDL cholesterol reduction: Genetics and therapeutic implications of very low plasma lipoprotein levels
- (2015) A. David Marais et al. PHARMACOLOGY & THERAPEUTICS
- PCSK9 inhibition in patients with hypercholesterolemia
- (2015) Nihar R. Desai et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Inhibition ofPCSK9Transcription by Berberine Involves Down-regulation of Hepatic HNF1α Protein Expression through the Ubiquitin-Proteasome Degradation Pathway
- (2014) Bin Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells
- (2014) Mi-Hsueh Tai et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: a randomized controlled trial
- (2014) Siv K. Bøhn et al. Food & Function
- PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells
- (2013) Emile Levy et al. ATHEROSCLEROSIS
- Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways
- (2013) Jia Xiao et al. EUROPEAN JOURNAL OF NUTRITION
- Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6
- (2013) Rongya Tao et al. JOURNAL OF LIPID RESEARCH
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of a common variant of the PCSK2 gene on reduced insulin secretion
- (2012) A. Jonsson et al. DIABETOLOGIA
- Hepatic-Specific Disruption of SIRT6 in Mice Results in Fatty Liver Formation Due to Enhanced Glycolysis and Triglyceride Synthesis
- (2010) Hyun-Seok Kim et al. Cell Metabolism
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started